These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23999299)

  • 21. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines.
    Hope R; Warner M; Mushtaq S; Ward ME; Parsons T; Livermore DM
    J Antimicrob Chemother; 2005 Dec; 56(6):1042-6. PubMed ID: 16286361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystallization and preliminary X-ray crystallographic analysis of the tetracycline-degrading monooxygenase TetX2 from Bacteroides thetaiotaomicron.
    Volkers G; Schuldt L; Palm GJ; Wright GD; Hinrichs W
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 May; 66(Pt 5):611-4. PubMed ID: 20445272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetracycline antibiotics and resistance mechanisms.
    Nguyen F; Starosta AL; Arenz S; Sohmen D; Dönhöfer A; Wilson DN
    Biol Chem; 2014 May; 395(5):559-75. PubMed ID: 24497223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of minocycline in humans.
    Nelis HJ; De Leenheer AP
    Drug Metab Dispos; 1982; 10(2):142-6. PubMed ID: 6124399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the dioxygen route in Melanocarpus albomyces laccase with pressurized xenon gas.
    Kallio JP; Rouvinen J; Kruus K; Hakulinen N
    Biochemistry; 2011 May; 50(21):4396-8. PubMed ID: 21524088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of two aromatic hydroxylases involved in the early tailoring steps of angucycline biosynthesis.
    Koskiniemi H; Metsä-Ketelä M; Dobritzsch D; Kallio P; Korhonen H; Mäntsälä P; Schneider G; Niemi J
    J Mol Biol; 2007 Sep; 372(3):633-48. PubMed ID: 17669423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structures of SnoaL2 and AclR: two putative hydroxylases in the biosynthesis of aromatic polyketide antibiotics.
    Beinker P; Lohkamp B; Peltonen T; Niemi J; Mäntsälä P; Schneider G
    J Mol Biol; 2006 Jun; 359(3):728-40. PubMed ID: 16650858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tigecycline: a review of properties, applications, and analytical methods.
    da Silva LM; Nunes Salgado HR
    Ther Drug Monit; 2010 Jun; 32(3):282-8. PubMed ID: 20431506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Oxoquinoline 8-monooxygenase oxygenase component: active site modulation by Rieske-[2Fe-2S] center oxidation/reduction.
    Martins BM; Svetlitchnaia T; Dobbek H
    Structure; 2005 May; 13(5):817-24. PubMed ID: 15893671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
    Rodríguez-Avial I; Rodríguez-Avial C; López O; Culebras E; Picazo JJ
    Int J Antimicrob Agents; 2006 Apr; 27(4):303-6. PubMed ID: 16540293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi.
    Ates L; Hanssen-Hübner C; Norris DE; Richter D; Kraiczy P; Hunfeld KP
    Ticks Tick Borne Dis; 2010 Mar; 1(1):30-4. PubMed ID: 21771509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
    Peleg AY; Adams J; Paterson DL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2065-9. PubMed ID: 17420217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and phylogenetic analysis of TetX variants to design a new classification system.
    Cheng Q; Cheung Y; Liu C; Chan EWC; Wong KY; Zhang R; Chen S
    Commun Biol; 2022 May; 5(1):522. PubMed ID: 35641548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tigecycline.
    Pankey GA
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xenon and halogenated alkanes track putative substrate binding cavities in the soluble methane monooxygenase hydroxylase.
    Whittington DA; Rosenzweig AC; Frederick CA; Lippard SJ
    Biochemistry; 2001 Mar; 40(12):3476-82. PubMed ID: 11297413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline: a new glycylcycline for treatment of serious infections.
    Noskin GA
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S303-14. PubMed ID: 16080069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of tigecycline against Bacteroides species.
    Betriu C; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
    J Antimicrob Chemother; 2005 Aug; 56(2):349-52. PubMed ID: 15951353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tigecycline: what is it, and where should it be used?
    Livermore DM
    J Antimicrob Chemother; 2005 Oct; 56(4):611-4. PubMed ID: 16120626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S; Lupo A; Mezzatesta ML; Campanile F; Santagati M; Stefani S
    Int J Antimicrob Agents; 2008 Mar; 31(3):209-15. PubMed ID: 17646087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.